OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,560
-290 (-2.67%)
At close: Mar 6, 2026
56.44%
Market Cap 179.29B
Revenue (ttm) 87.58B
Net Income (ttm) 11.18B
Shares Out 17.65M
EPS (ttm) 731.00
PE Ratio 13.90
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 273,866
Average Volume 1,094,982
Open 10,850
Previous Close 10,850
Day's Range 10,240 - 11,180
52-Week Range 5,610 - 14,040
Beta 0.66
RSI 54.41
Earnings Date Jan 23, 2026

About OPTUS Pharmaceutical

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Cheongju, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 159
Stock Exchange KOSDAQ
Ticker Symbol 131030
Full Company Profile

Financial Performance

In 2024, OPTUS Pharmaceutical's revenue was 81.90 billion, an increase of 13.09% compared to the previous year's 72.43 billion. Earnings were 10.31 billion, a decrease of -4.20%.

Financial Statements

News

There is no news available yet.